Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butantan inactivated COVID-19 vaccine study in immunocompromised adults
RBR-9ksh5f4Phase 4Not yet recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- May 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial in coronavirus disease 2019 (COVID-19) (11 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Seroconversion rate and Geometric mean antibody titers. Planned start May 2021; status: not yet recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-9ksh5f4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9ksh5f4.